Image

Systolic Function and Weaning-induced Pulmonary Edema (SystoWean Study)

Systolic Function and Weaning-induced Pulmonary Edema (SystoWean Study)

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The purpose of this study is to determine if the left and right ventricular systolic function is involved in the development of weaning failure related to weaning-induced pulmonary edema.

Description

Weaning from mechanical ventilation remains a central step in the management of critically-ill patients, since weaning failure and prolonged duration of mechanical ventilation are not only associated with an increase in the length of stay in intensive care but also with greater morbidity and mortality. One of the well-recognized causes of weaning failure is weaning-induced pulmonary edema (WIPO), which accounts for almost 60% of the causes of weaning failure and ranging up to 75% in high-risk patients, i.e. patients with medical history of chronic heart disease, chronic respiratory failure and obesity.

Echocardiography is increasingly used in intensive care and allows non-invasive assessment of diastolic function as well as left ventricular (LV) and right (RV) systolic function, including during a spontaneous breathing test. Although LV diastolic dysfunction appears to be a major determinant of WIPO, the role of LV and RV systolic dysfunction is less unequivocal and has been poorly studied so far. Scarce data showed that patients experiencing WIPO tended to exhibit more frequently LV systolic dysfunction, as demonstrated by a lower LV ejection fraction (LVEF) and no study but two have investigated the potential role of RV systolic function. Moreover, assessing LV systolic function with LVEF measurement suffers from several limitations, especially in critically-ill patients.

Thus, the main goal of this study is to investigate whether LV and RV systolic function is involved in the development of WIPO. The second goal of this study is to determine the best echocardiographic parameter to assess LV and RV systolic function during the weaning process.

Eligibility

Inclusion Criteria:

  1. Invasive mechanical ventilation for more than 48 hours
  2. Patients indicated, according to intensivists, for carrying out a spontaneous breathing trial weaning test, based on the presence of all of the following criteria:
    1. SpO2> 90% with FiO2 ≤40% and PEEP ≤5 cmH2O
    2. Cough effectiveness on tracheal aspirations
    3. Lack of hemodynamic instability and of disorders of consciousness
  3. Patients at high risk of weaning-induced pulmonary edema (WIPO), defined by one or

    more of the following criteria:

    1. Obesity, defined by a body mass index> 30 kg/m²
    2. Chronic obstructive pulmonary disease
    3. Chronic heart disease

Exclusion Criteria:

  1. Age <18 years and pregnant women
  2. Patients with a decision of not to resuscitate
  3. Poor echogenicity
  4. Severe mitral valve disease (leakage and/or stenosis, bioprosthesis)
  5. Patients with pacemaker
  6. Tracheostomy
  7. Chronic neuromuscular or neurodegenerative diseases

Study details
    Mechanical Ventilation Complication
    Pulmonary Edema

NCT05226247

Centre Hospitalier Universitaire de Nice

15 February 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.